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ABSTRACT  
Background 
An implanted device for brain-responsive neurostimulation (RNS System) is approved as an 
effective treatment to reduce seizures in adults with medically-refractory focal epilepsy. Clinical 
trials of the RNS System demonstrate population-level reduction in average seizure frequency, 
but therapeutic response is highly variable.  
 
Hypothesis 
Recent evidence links seizures to cyclical fluctuations in underlying risk. We tested the 
hypothesis that effectiveness of responsive neurostimulation varies based on current state within 
cyclical risk fluctuations. 
 
Methods 
We analyzed retrospective data from 25 adults with medically-refractory focal epilepsy 
implanted with the RNS System. Chronic electrocorticography was used to record electrographic 
seizures, and hidden Markov models decoded seizures into fluctuations in underlying risk. State-
dependent associations of RNS System stimulation parameters with changes in risk were 
estimated.  
 
Results  
Higher charge density was associated with improved outcomes, both for remaining in a low 
seizure risk state and for transitioning from a high to a low seizure risk state. The effect of 
stimulation frequency depended on initial seizure risk state: when starting in a low risk state, 
higher stimulation frequencies were associated with remaining in a low risk state, but when 
starting in a high risk state, lower stimulation frequencies were associated with transition to a 
low risk state. Findings were consistent across bipolar and monopolar stimulation configurations.  
 
Conclusion 
The impact of RNS on seizure frequency exhibits state-dependence, such that stimulation 
parameters which are effective in one seizure risk state may not be effective in another. These 
findings represent conceptual advances in understanding the therapeutic mechanism of RNS, and 
directly inform current practices of RNS tuning and the development of next-generation 
neurostimulation systems. 
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INTRODUCTION 
Epilepsy is a common neurological disorder characterized by recurrent seizures. Anti-seizure 
medications are first-line treatments for epilepsy, but up to 30% of patients have seizures that are 
incompletely controlled with medications. For these medically-refractory patients, resection of 
the seizure focus can be highly effective but may not be possible if seizure foci are bilateral, 
poorly localized, spatially-extensive, or overlapping with eloquent cortex. 
 
In recent years, responsive neurostimulation (RNS), brain electrical stimulation triggered by real-
time detection of seizures, has emerged as promising therapy for medically-refractory patients 
who are not candidates for resective surgery. The RNS System (NeuroPace, Inc.) is a cranially-
implanted device approved as a safe and effective treatment for adults with medically-refractory 
seizures arising from 1–2 foci. In clinical trials, RNS System treatment results in median seizure 
frequency reduction of 75% after nine years (1, 2). However, therapeutic response to RNS is 
highly variable across individuals. Up to one-third of patients have a dramatic response to RNS 
with ≥90% seizure frequency reduction (2), but about one-quarter of patients are non-responders 
with less than 50% reduction in seizure frequency (1). Investigations of factors that predict 
therapeutic response to RNS have focused primarily on stationary clinical features, such as the 
presence of mesial temporal sclerosis, seizure focus, prior resection, prior intracranial 
monitoring, or lead proximity to the seizure focus (3-5). However, no features have yet been 
found to explain this variability (3-5). Improving outcomes for all patients treated with RNS, 
particularly non-responders, may be facilitated by greater mechanistic understanding of this 
therapy and optimization of stimulation protocols based on individual temporal dynamics. 
 
Prevailing views on the mechanistic basis of RNS have shifted over time. Originally, the efficacy 
of RNS was thought to derive from direct inhibition of ongoing seizures by electrical stimulation 
(6-8); in other words, RNS was thought to abort seizures in the way that defibrillators terminate 
cardiac arrhythmias. However, a critical observation from long-term clinical trials is that the 
efficacy of RNS improves over time (1, 2), suggesting chronic, neuromodulatory effects in 
addition to acute seizure-terminating effects. Still, many questions remain about how best to 
harness the putative neuromodulatory effects of RNS. These effects likely depend on the 
stimulation parameters that are employed (9, 10), but aside from experience-based practice, there 
are virtually no objective methods for selecting these parameters rationally. For example, based 
on experience during clinical trials, charge density is often increased empirically to enhance 
therapeutic response, but a definitive correlation between charge density and seizure frequency 
has not been shown (5).  
 
Emerging research indicates that epilepsy is a cyclical disorder. Rates of interictal epileptiform 
discharges (IEDs) fluctuate with daily and multi-day periodicities (11-18). Electrographic 
seizures occur preferentially at certain phases of these IED cycles, which therefore help 
determine momentary seizure risk (18, 19). Periods of high and low seizure risk in IED 
fluctuations can be conceptualized as distinct brain states oscillating with hours-to-months long 
macro periodicities, which may have varying susceptibility to neurostimulation. In vitro and in 
vivo models suggest that neural modulation using electrical stimulation is state-dependent (20, 
21). Despite these discoveries, RNS System programming in contemporary practice remains 
empiric and agnostic to brain state. Standardized titration schedules for stimulation parameters 
are applied to patients with diverse epilepsies (22), and parameters are adjusted relatively 
infrequently. Thus, the dynamism of brain states in epilepsy based on macro oscillations of IEDs 
contrasts sharply with clinical management of RNS. Whether electrical stimulation protocols can 
be tailored in a patient-specific, time-varying manner to increase response rates is unknown. 
 
Here, we hypothesize that the ability of electrical stimulation to modulate seizures is state-
dependent, and, specifically, that stimulation parameters that are effective in one brain state may 
not be effective in another brain state. To test this, we investigate the effect of electrical 
stimulation parameter changes on the incidence of electrographic seizures as a state-dependent 
function in a retrospective cohort of 25 adults with medically-refractory focal epilepsy treated 
with the RNS System. 
 
  
MATERIAL AND METHODS 
Patient selection 
We performed a retrospective review of patients with medically-refractory focal epilepsy who 
were implanted with the RNS System for clinical indications between August 2014 and June 
2018 at the University of California, San Francisco (UCSF) Comprehensive Epilepsy Center. 
Data collection was approved by the UCSF Institutional Review Board and written informed 
consent was obtained from all subjects.  
 
RNS System 
The RNS System is comprised of a cranially-implanted programmable neurostimulator which is 
connected to two four-contact depth or cortical strip leads placed at the seizure focus/foci. The 
neurostimulator continuously senses electrocorticographic (ECoG) activity and is programmed 
by clinicians to detect specific patterns and deliver brief electrical pulses through the electrode 
contacts in response to those detections. Electrographic seizures are identified either through 
saturations (high amplitude ECoG) or Long Episodes (LE, sustained detections of abnormal 
brain activity that often represent seizures). Detection and stimulation parameters are adjusted 
based on clinical factors for each patient. Stimulation parameters that can be adjusted include the 
charge density (current amplitude x pulse width per phase, distributed over the number of 
cathodes), stimulation frequency (rate at which pulses are delivered), burst duration (amount of 
time for each train of pulses), and pulse width (duration of a single phase within a charge-
balanced biphasic square-wave pulse). Most commonly, charge density, stimulation frequency, 
and burst duration are adjusted. Stimulation can be applied using various ‘stimulation pathways,’ 
designations of the eight electrode contacts as anodes or cathodes. The most common stimulation 
pathways are a bipolar pathway (alternating anodal and cathodal contacts on each lead) or 
cathodal pathway (with one lead the anode and one lead the cathode; when leads are far apart, 
this approximates monopolar stimulation). The neurostimulator canister can also be used as an 
anode or cathode in a lead-to-generator montage within a cathodal/monopolar pathway. A 
grouped bipolar stimulation pathway (alternating pairs of anodal and cathodal electrode contacts) 
is less commonly used. Examples of bipolar, grouped bipolar, and cathodal/monopolar pathways 
are shown in Table 1.  
 
RNS System stimulation parameters (charge density, frequency, burst duration, pulse width) and 
stimulation pathway were determined by treating providers based on clinical information. All 
patients had two four-contact depth and/or cortical strip leads placed over the seizure-onset 
zone(s). Computed tomography brain imaging was performed post-operatively to confirm lead 
placement. For each patient, the number of LE detections, stimulation settings (charge density, 
frequency, burst duration, pulse width), and stimulation pathway at each hour were recorded. 
Stimulation parameters used in the first therapy delivered by the device during each detection 
episode were analyzed. 
 
Data collection  
RNS System stimulation settings and hourly LE counts were extracted from the Patient Data 
Management System (PDMS), a secure online repository of RNS System programming 
parameters and electrographic data. Stimulation pathways were analyzed separately. Less than 
0.1% of the data had non-consecutive breaks in recorded hourly counts. All related clinical data 
were abstracted from the electronic medical record system.  
 State-dependent modeling of parameter associations with long episodes 
LE detections were used to identify electrographic seizures. All ECoG recordings were manually 
reviewed by an experienced epileptologist (VRR) to confirm whether long episodes 
corresponded to electrographic seizures. Only patients for whom >90% of LE’s detected by the 
RNS System corresponded to electrographic seizures (19) and for whom there were at least 20 
time points in one of the stimulation configurations were included. A first-order non-
homogeneous hidden Markov model for zero-inflated count data was used to identify whether 
stimulation parameters differed in effectiveness depending on current state (11, 12). This implies 
a future risk prediction horizon of one hour ahead, conditioned on the risk state of the previous 
hour.  Non-homogeneous hidden Markov models are a class of latent process models that can be 
used to decode electrographic seizures into underlying latent (unobserved) levels of seizure risk, 
while simultaneously estimating the association of exogenous inputs at each time t (here, RNS 
stimulation parameters) with changes in latent risk from time t to t+1 (Figure 1). The temporal 
directionality of this inference allows for causal inference to be drawn. The latent process 
approach has several advantages: firstly, it reduces noise of count data; secondly, it explicitly 
accounts for conditional associations between RNS stimulation parameters and changes in risk 
conditional on current state; thirdly, the temporal directionality relating exogenous inputs to 
changes in risk allows for causal inference between RNS parameters and changes in risk. If the 
association between RNS stimulation parameters and seizure risk is independent of current state, 
then estimated conditional associations will not significantly differ. For a more in-depth 
overview of Bayesian inference, we refer the reader to (23). 
 
 Figure 1. Hidden Markov modeling of effect of RNS stimulation on seizure modulation. A hidden 
Markov model captures the temporal evolution of seizure risk states, consisting of a Markov chain with 
stochastic measurements on the hidden states (blue) and emission distribution conditional on the states 
(orange). Non-homogeneity of the hidden Markov process allows the transition matrix of the hidden 
states to depend on RNS parameter changes and other exogenous variables (grey). Abbreviations: RNS, 
responsive neurostimulation. 
 
Markov chain Monte Carlo (MCMC) sampling was used to sample from the posterior 
distribution of parameters, which yields posterior estimates of the association of exogenous 
inputs with seizure risk state transitions. We analyzed the association of commonly adjusted 
RNS stimulation parameters, including charge density, pulse frequency, and burst duration, with 
state transitions. Pulse width was excluded from bipolar and cathodal analyses, as this parameter 
is less commonly manipulated than charge density, pulse frequency, burst duration, or 
stimulation pathway. Burst duration was included only in cathodal analysis, as the only value of 
burst duration used in patients employing a bipolar stimulation configuration was 100 ms. In 
addition, we controlled for several other baseline characteristics within the hidden Markov 
model, including age, sex, and seizure focus (mesiotemporal, neocortical, or both).(5) To account 
for potential influence of device detection sensitivity on long episode counts, the number of 
episode starts was additionally included. For each configuration, we explored model fits with K 
between 2 and 3 states to find the number of states K yielding the best model fit. Model fit for 
each value of K was assessed using the deviance information criterion (24) and convergence of 
the state allocations to the stationary distribution. For clinical interpretability, we used K=2 
states, which allows for interpretation of high and low seizure risk states. Convergence of each 
chain was assessed based on trace plots and the Raftery-Lewis diagnostic. Posterior means and 
95% highest posterior density (HPD) intervals for multinomial logit coefficients were computed 
to estimate the association between neurostimulation parameter values with state transitions. 
Posterior estimates of states were computed based on the posterior mode. Full Bayesian 
significance testing was performed based on whether the 95% HPD interval contains zero (25). 
Zero-valued coefficients mean that there is insufficient evidence to suggest that the stimulation 
parameter is associated with the improvement or worsening in seizure risk. Non zero-valued 
coefficients mean that there is evidence that the stimulation parameter is associated with the 
improvement or worsening in seizure risk.  
 
  
RESULTS 
From a total cohort of 49 patients implanted with the RNS System at our center between August 
2014 and June 2018, we identified 25 patients with available data for whom LE reliably 
corresponded to electrographic seizures (see Methods). These patients represented a total 
accumulated experience of 286,473 patient-hours of treatment with the RNS System.  
 
Demographic characteristics 
Demographic characteristics are provided in Table 2. The mean age at time of RNS System 
implantation was 38.7±13.9 years (range, 18.2-72.0 years). A greater proportion of patients 
treated with bipolar stimulation had a mesiotemporal focus, whereas a greater proportion of 
patients treated with cathodal stimulation had a neocortical focus (p=0.003). Cathodal and 
bipolar cohorts were otherwise similar in age, sex, seizure frequency, age of epilepsy onset, 
epilepsy duration, and epilepsy etiology (Table 2). The average epilepsy duration was 21.6±13.0 
years (range 2.0-61.0 years). The most common etiology of epilepsy was cryptogenic (54.2%). 
 
RNS System parameters 
Stimulation was enabled on the RNS System once reliable seizure detection was achieved. Initial 
RNS System stimulation parameters were empirically selected and iteratively adjusted based on 
the patient’s clinical course and experience from the RNS System Clinical Trials. A cathodal 
stimulation pathway was used in 13/25 patients and a bipolar stimulation pathway was used in 
16/25 patients. The grouped bipolar stimulation pathway was used temporarily in only one 
patient, with the same stimulation settings used during the entire duration of grouped bipolar 
stimulation (charge density of 2.0 μC/cm2, frequency of 200 Hz, pulse width of 160 μs, and burst 
duration of 100 ms) and was thus excluded from analysis. Of the 25 patients, 8 patients were 
treated only with cathodal stimulation, 12 patients were treated only with bipolar stimulation, 
four were initially treated with bipolar stimulation and then switched to cathodal stimulation, and 
one patient was treated initially with cathodal stimulation and then switched to grouped bipolar 
stimulation. A total of 150,238 person-hours from 13 patients were available for analysis in the 
cathodal stimulation configuration and 130,266 person-hours were available from 16 patients in 
the bipolar stimulation configuration.  
 
Cathodal stimulation pathway 
State allocations showed convergence to a stationary distribution for K=2. For interpretation, we 
thereon refer to the two ordered states as a high and low seizure risk state. Figure 2 shows an 
example of the posterior estimates of seizure risk states based on the number of ‘long episodes’ 
(electrographic seizures) per hour, for a patient with RNS in the cathodal stimulation 
configuration. The Markovian property accounts for memory when identifying seizure risk 
states. This permits, for example, continuous sequences of zero seizures per hour with only a few 
interspersed hours with one or two seizures to be identified as low risk despite the presence of a 
few hours with seizures; conversely, a continuous sequence of hours with many seizures 
occurring, with only a few interspersed hours with no seizures, can be identified as high risk 
despite the potentially random occurrence of a few hours without seizures. This reduces the noise 
inherent in seizure counting data by probabilistically discriminating between natural variability 
and sustained changes in risk. The distribution of seizures classified in high and low risk states is 
shown in Supplementary Figure A1.  
 
 Figure 2. Estimated latent seizure risk states for a time sample from an example RNS patient. 
Number of long episodes per hour is shown in black. Seizure risk state estimates, based on the mode of 
the posterior distribution of latent states, are shown in red. Abbreviations: RNS, responsive 
neurostimulation. 
 
Using a cathodal stimulation configuration, the mean stimulation parameter setting over 150,238 
person-hours was a charge density of 1.7+0.7 μC/sq cm, pulse frequency of 189.2+54.5 Hz, burst 
duration of 468.7+1234.7 ms, and pulse width of 155.5+12.7 μs. Stimulation parameters are 
shown in Table 3 and Figure 3A. Figure 4A shows the association of stimulation parameters with 
changes in seizure risk state for the cathodal configuration, with posterior means and HPD 
intervals in Supplementary Table A1. For time points when patients were currently in a low 
seizure risk state (Figure 4A, green circles), using a higher charge density, higher stimulation 
frequency, or shorter burst duration were associated with better chance of remaining in a low 
seizure risk state. For time points when patients were currently in a high seizure risk state (Figure 
4A, red circles), using a lower stimulation frequency or shorter burst duration were associated 
with a higher probability of transitioning from a high to a low seizure risk state (Figure 4A, 
Supplementary Table A1). Robustness of results in the cathodal stimulation configuration was 
compared to when the subset of four patients with preceding bipolar stimulation were excluded 
(i.e., with analysis restricted to patients treated only with cathodal stimulation). Subgroup 
analysis demonstrated consistent associations of higher charge density, higher stimulation 
frequency, and shorter burst duration with improved chance of remaining in a low seizure risk 
state with cathodal stimulation, as well as consistent associations between lower stimulation 
frequency and shorter burst duration with higher probability of transitioning from a high to a low 
seizure risk state. A near-zero (HPD interval, -0.42 to -0.06) inverse association between charge 
density and probability of transitioning from a high to low seizure risk state was present when 
analysis was limited to the subset of patients treated only with cathodal stimulation 
(Supplementary Figure A1, Supplementary Table A2).  
 
Bipolar stimulation pathway 
Using a bipolar stimulation montage, the mean stimulation parameter setting over 130,266 
person-hours was a charge density of 2.1+0.8 μC/sq cm, pulse frequency of 198.5+12.1 Hz, burst 
duration of 100 ms, and pulse width of 157.6+9.5 μs. Figure 4B shows the association of 
stimulation parameter changes with electrographic seizure counts contingent on current state 
values for the bipolar stimulation configuration, with posterior means and HPD intervals in 
Supplementary Table A3. Higher charge densities were associated with better chances of 
remaining in a low seizure risk state (for times when patients were already in low risk states) as 
well as better chance of transitioning from a high to low seizure risk state (for times when 
patients were in high risk states). For times when patients were currently in a low seizure risk 
state, higher stimulation frequencies were associated with remaining in low risk states. For time 
points when patients were currently in a high seizure risk state, lower stimulation frequencies 
were associated with transitioning from a high to low seizure risk state (Figure 4B, 
Supplementary Table A3). 
 
 
Figure 3. RNS stimulation parameters: combinations of stimulation parameters used by clinicians 
within each stimulation pathway are shown. Abbreviations: RNS, responsive neurostimulation. 
 
 
Figure 4. Association of increases in RNS stimulation parameters with low future seizure risk, for 
(a) cathodal and (b) bipolar stimulation configuration. Posterior means and 95% highest posterior 
density (HPD) intervals for state-dependent log-odds of each stimulation parameter for transitioning to a 
low risk state are shown, conditional on current risk state (shown in red and green). Probabilities are 
relative to the probability of transitioning to (or remaining in) a high risk state. * = 95% HPD interval 
does not contain zero. Abbreviations: RNS, responsive neurostimulation. 
 
 
 
  
DISCUSSION 
In contemporary practice, RNS stimulation parameters are adjusted empirically and typically 
held constant for months, a timeframe during which there may be considerable fluctuation in 
underlying seizure risk. Here, we demonstrate that RNS charge density can modulate seizure risk 
and that, for the two most common stimulation pathways, the effects of changing other 
stimulation parameters depend on initial seizure risk state. This suggests that variability in 
clinical response to RNS may relate at least partly to counterproductive effects of stimulation 
parameter changes applied during inopportune brain states. These data also suggest that next-
generation neurostimulation systems for epilepsy may benefit from real-time feedback and 
adaptive stimulation capabilities that continuously monitor brain state over prolonged periods of 
time, which may minimize interpatient variability and enhance clinical outcomes.  
 
Our results provide several conceptual advances in understanding the relationship between 
electrical brain stimulation and seizure risk. First, we show that the impact of responsive 
neurostimulation on modulating seizure frequency may exhibit state-dependence, and that 
stimulation parameters which are effective in one brain state may not be effective, or even have 
opposite effects, in another brain state. In vitro and in vivo animal models have revealed that the 
modulatory impact of electrical stimulation is frequency-dependent and timing-dependent (21, 
26, 27), but, to our knowledge, this is the first demonstration in human neuromodulation 
protocols in epilepsy. A state-based view of electrical stimulation paradigms implies that the 
impact of neurostimulation extends beyond direct seizure termination, consistent with an 
emerging concept of RNS having long-term neuromodulatory effects (28) that facilitate 
transitions from high and low seizure risk states, which may bear an indirect relation to cortical 
“up” and “down” states. We speculate that these effects may involve state-specific disruption of 
pathological cortical synchrony.  
 
Second, we discover several new state-dependent effects of various neurostimulation parameters 
which may catalyze future development of adaptive neurostimulation systems. Currently, the 
recommended initial settings for the RNS System are: frequency 200 Hz, burst duration 100 ms, 
charge density 0.5 μC/cm2, and pulse width 160 μs. Over time, current recommendations are to 
increase charge density stepwise in 0.5 μC/sq cm increments.(22) If this fails, burst duration and 
frequency are often increased, although specific guidelines for these adjustments are not 
available. Despite these recommendations, empirical evidence supporting these 
recommendations has not previously been shown. In clinical practice, the most commonly 
programmed stimulation parameters are an amplitude of 1.5–3.0 mA, pulse width of 160 μs, 
burst duration of 100–200 ms, and pulse frequency of 100–200 Hz (29, 30). For both bipolar and 
cathodal stimulation configurations, we found that higher charge densities were associated with 
improved outcomes, both for remaining in (bipolar/cathodal) or transitioning to (bipolar) a low 
seizure risk state. Bipolar stimulation exerts a more focal stimulation effect than cathodal 
stimulation, such that increases in charge density may make more of a difference for bipolar 
pathways. Within the range of 100–5000 ms, shorter burst durations were associated with 
remaining in or transitioning to low seizure risk states in cathodal configurations (not evaluated 
in bipolar configuration due to lack of variability in the bipolar sample).  However, depending on 
whether the patient was currently in a low or high risk state, increasing stimulation frequency 
could either lead to a worsening or improvement in seizure risk. Specifically, higher stimulation 
frequencies were more likely to result in patients remaining in a low seizure risk state, but, if the 
patient started in a high seizure risk state, a lower stimulation frequency was more likely to 
transition the patient to a low seizure risk state. This finding was consistent across both bipolar 
and cathodal stimulation configurations, as well as when the subset of patients with multiple 
stimulation configurations was excluded. These results provide evidence to support the empiric 
recommendation to increase charge density as a first step for patients with subtherapeutic 
responses to neurostimulation. However, these findings also suggest that the effectiveness of 
other stimulation parameters, such as stimulation frequency, may depend on the current seizure 
risk state. Differential state-dependent effects of adjusting frequency may explain why the initial 
recommended frequency setting for RNS is 200 Hz in RNS but parameter settings usually end up 
ranging between 100-200 Hz. Adaptive approaches to adjusting stimulation parameters may 
benefit from real-time evaluation of seizure risk state with dynamic online adjustment of 
stimulation parameters. State-dependent effectiveness of stimulation parameters may suggest a 
strategy of differentially programming stimulation parameters for different “therapies” (bursts of 
current pulses) that are delivered within a given detection epoch if redetection of the 
electrographic seizure occurs. Up to five therapies can be delivered if redetection of the 
electrographic seizure occurs despite the preceding therapies. Because persistence of a seizure 
despite repeated therapies is more likely to reflect a high risk state, we postulate that a 
differential programming strategy may improve effectiveness, with parameters for the first 
therapy set to those effective in low risk states, and parameters for later therapies set to those 
effective in high risk states.  
 
There are several limitations to this study. The patient sample, while spanning a wide range of 
ages and localizations of epilepsy, was modest in size and may not be representative of all 
patients implanted with the RNS System. The minimum age evaluated in this sample was 18 
years; given increasing interest in RNS use in the pediatric epilepsy population (31, 32), 
generalizability to pediatric populations is of interest. Due to storage limitations, the RNS 
System does not provide continuous ECoG tracings, so electrographic seizure detections were 
based on “long episodes,” which are an imperfect surrogate for seizures. However, the fact that 
we only included patients for whom >90% of long-episodes corresponded to electrographic 
seizures may mitigate this concern. Patients may differ with respect to the number of seizure 
states that they cycle through. The number of states used was chosen for interpretability and 
consistent interpretability in groupwise conclusions. However, if state-dependent electrical 
stimulation is used in an adaptive stimulation paradigm, it would be beneficial to allow for a 
varying number of states optimized to the individual patient. Larger samples will be useful for 
validating these findings across a greater variety of parameter changes, particularly for bipolar or 
grouped bipolar configurations. Although we speculate here on translatability to comparing 
bipolar and cathodal stimulation pathways, small sample sizes and limited matching 
characteristics caution against direct comparability of these montages and is outside the scope of 
this study. Larger matched samples are needed for direct comparison of stimulation pathways.  
Finally, randomized prospective trials to confirm differences among parameter effects and 
stimulation configurations are needed. Since bipolar montages tend to be trialed first, differences 
between bipolar and cathodal montages may reflect differences in timing. In our sample, 4 of the 
13 patients with cathodal stimulation had bipolar stimulation first; however, sensitivity analysis 
demonstrated robustness to exclusion of these patients. 
 
In conclusion, our findings provide evidence to support potential state-dependence for the 
effectiveness of RNS in modulating seizure frequency. This finding provides a possible 
explanation for variations in efficacy of RNS electrical stimulation on modulating seizures and 
suggests the need for incorporating real-time state analysis into adaptive algorithms for future 
neurostimulation systems.  
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